Fate Therapeutics Inc Stock Performance
as on March 21, 2026 at 6:59 am IST
Day's Low
Day's High
$1.06$1.12
3.64%
Downside
1.82%
Upside
52 Week's Low
52 Week's High
$0.66$1.9439.90%
Downside
76.35%
Upside
Fate Therapeutics Inc share price movements today
- Previous Close
- $1.08
- Open
- $1.09
- Volume
- 3.9M
- Day's Low - High
- $1.06 - $1.12
- 52 Week Low - High
- $0.66 - $1.94
Fate Therapeutics Inc Historical Returns
- 1 Month Return
- -24.66 %
- 3 Month Return
- + 4.76 %
- 1 Year Return
- + 20.36 %
- 3 Year Return
- -79.7 %
- 5 Year Return
- -98.78 %
Fate Therapeutics Inc Stock Fundamentals & Key Indicators
Check Fate Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$125.6M
EPS (TTM)
-1.1643
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.29
Industry PE ratio
-4.746406779661017
PEG Ratio
0EBITDA
-133.7M
Revenue (TTM)
6.6M
Profit Margin
0.00%
Return On Equity TTM
-51.84%
Fate Therapeutics Inc Stock Valuation
Track how Fate Therapeutics Inc P/E has moved over time to understand its valuation trends.
Fate Therapeutics Inc in the last 5 years
Lowest (-45.20x)
March 31, 2021
Industry (-4.75x)
March 21, 2026
Today (-2.29x)
March 21, 2026
Highest (-0.80x)
June 30, 2025
Today’s Price to Earnings Ratio: -2.29x
Fate Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Fate Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $125.6M | -98.78% | -2.29 | 0.00% | |
| BUY | $41.3B | 116.54% | 133.52 | 8.45% | |
| BUY | $116.3B | 110.08% | 29.94 | 32.94% | |
| NA | $32.5B | NA | 114.93 | 5.37% | |
| BUY | $78.0B | 54.71% | 17.8 | 31.41% |
Stock Returns calculator for Fate Therapeutics Inc Stock including INR - Dollar returns
The Fate Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Fate Therapeutics Inc investment value today
Current value as on today
₹1,30,324
Returns
₹30,324
(+30.32%)
Returns from Fate Therapeutics Inc Stock
₹20,879 (+20.88%)
Dollar Returns*
₹9,445 (+9.44%)
Analyst Recommendation on Fate Therapeutics Inc Stock
Based on 26 analysts
42.31%
Buy
53.85%
Hold
3.85%
Sell
Based on 26 analysts, 53.85% of analysts recommend a 'HOLD' rating for Fate Therapeutics Inc. Average target price of $4.94
Fate Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Fate Therapeutics Inc.
What analysts predicted
77.73%UPSIDE
Target Price
$4.94
Current Price
$1.1
Analyzed by
26 Analysts
Target
$4.94
Fate Therapeutics Inc target price $4.94, a slight upside of 77.73% compared to current price of $1.1. According to 26 analysts rating.
Fate Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Fate Therapeutics Inc Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Fate Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Fate Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Fate Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Fate Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Fate Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, FATE has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 3 years, Fate Therapeutics Inc has experienced a drawdown of -78.6%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 76.1%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 1.90M → 1.36M (in $), with an average decrease of 15.0% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -32.25M → -32.37M (in $), with an average decrease of 0.4% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, FATE stock has moved down by -24.7%
About Fate Therapeutics Inc
| Organisation | Fate Therapeutics Inc |
| Headquarters | 12278 Scripps Summit Drive, San Diego, CA, United States, 92131 |
| Industry | Health Technology |
| CEO | Dr. Bahram Valamehr M.B.A., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Fate Therapeutics Inc
Name | Title |
|---|---|
Mr. Kamal Adawi M.S., MBA | Chief Financial Officer |
Dr. Martin Hosking | Head of Research |
Mr. Ryan Douglas | Senior Director of Investor Relations & Business Development |
Mr. Andrew Henry | Senior Vice President of Clinical Operations |
Dr. Bahram Valamehr M.B.A., Ph.D. | President, CEO & Director |
Ms. Cindy R. Tahl J.D. | Chief Legal & Compliance Officer and Corporate Secretary |
Ms. Jessica Francis | Senior Vice President of Human Resources & Operations |
Dr. Tunde Babalola Ph.D. | Senior Vice President of Technical Operations & Quality |
Dr. Yu Cai J.D., Ph.D. | Head of Intellectual Property & Assistant General Counsel |
Ms. Kate Duvall | Corporate Controller |
FAQs
What is Fate Therapeutics Inc share price today?
Fate Therapeutics Inc share price today is $1.1 as on at the close of the market. Fate Therapeutics Inc share today touched a day high of $1.12 and a low of $1.06.
What is the 52 week high and 52 week low for Fate Therapeutics Inc share?
Fate Therapeutics Inc share touched a 52 week high of $1.94 on and a 52 week low of $0.66 on . Fate Therapeutics Inc stock price today i.e. is closed at $1.1,which is 43.30% down from its 52 week high and 66.40% up from its 52 week low.
What is Fate Therapeutics Inc's market capitalisation today?
Fate Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Fate Therapeutics Inc Stock (FATE) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Fate Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Fate Therapeutics Inc Shares that will get you 1.3636 shares as per Fate Therapeutics Inc share price of $1.1 per share as on March 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Fate Therapeutics Inc Stock (FATE) from India?
Indian investors can start investing in Fate Therapeutics Inc (FATE) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Fate Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Fate Therapeutics Inc share’s latest price of $1.1 as on March 21, 2026 at 1:29 am IST, you will get 9.0909 shares of Fate Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Fate Therapeutics Inc has given to Indian investors in the last 5 years?
Fate Therapeutics Inc stock has given -98.78% share price returns and 28.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?